Mechanism of Action Stimulates melanocortin receptors in the central nervous system Triggers dopaminergic pathways that control sexual desire and arousal Enhances readiness for intimacy without needing sexual stimulation beforehand Intranasal delivery bypasses the digestive tract for fast systemic absorption Onset of action: approximately 1530 minutes Duration of effects: typically 48 hours Clinical Indications This nasal spray is used to treat or support: Hypoactive Sexual Desire Disorder (HSDD) in pre- and postmenopausal women Sexual arousal difficulties in men and women Erectile dysfunction (ED) with a psychological or neurogenic basis Libido decline related to aging, stress, SSRIs, or hormonal therapy Performance anxiety and intimacy issues in otherwise healthy individuals PT-141 nasal spray is especially useful for individuals who prefer non-injectable options and desire discreet, self-directed use

Supplies and Instructions Administration supplies, storage information and treatment-regimen instructions when applicable
Mechanism Selective NNMT inhibition, proposed to preserve intracellular NAD+/SAM and reduce fat-cell lipogenesis demonstrated in mice, not humans
With the lines blurring between implicit and explicit marketing, regulating the messaging around anti-obesity drugs as a quick fix for losing weight will require proactive efforts by brands, marketers and the regulators.
Carnitines role in brain health: Besides fertility, carnitine is implicated in brain plasticity and cognitive functions, with acetylcarnitine influencing gene expression through histone acetylation